Distillation is widely used in pharmaceutical processing for purification, solvent handling and separation. However, molecular distillation is a more specialized process intended for materials that are difficult to handle by conventional distillation—particularly high-boiling, heat-sensitive and high-value liquid mixtures.

In pharmaceutical and related processing, molecular distillation is most relevant when the product cannot tolerate prolonged heating and the separation can be achieved by differences in volatility under deep vacuum.

It is therefore not a replacement for every pharmaceutical distillation process. It is one option for selected intermediates, natural-product fractions, vitamins, oils and other thermally sensitive materials. Reviews of molecular distillation applications particularly highlight pharmaceutical raw materials, natural products, fixed oils, essential oils and bioactive compounds.

When Is Molecular Distillation Used in the Pharmaceutical Industry?

Conventional distillation, fractional distillation and vacuum distillation remain appropriate for many pharmaceutical separations, especially solvent recovery and relatively volatile mixtures.

Molecular distillation becomes more attractive when several conditions occur together:

  • The target material has a high boiling point.
  • The product is thermally sensitive.
  • Long residence time at elevated temperature may cause degradation.
  • The feed contains lower-boiling impurities or fractions that can be separated under deep vacuum.
  • The product has enough value to justify specialized high-vacuum equipment.
  • The material can form a stable thin film inside the evaporator.

A wiped-film molecular still combines a thin liquid film, deep vacuum, short residence time and an internal condenser positioned close to the evaporation surface. This reduces both thermal exposure and vapor-path pressure loss.

What Pharmaceutical Materials Can Be Processed by Molecular Distillation?

Molecular distillation should be selected from the actual feed composition and separation target, not simply because a product is described as pharmaceutical.

1. Vitamins and Tocopherol-Rich Fractions

Vitamin E recovery is one of the better documented molecular-distillation applications.

Research on soybean-oil deodorizer distillate has shown that evaporator temperature, feed rate and residence time strongly affect tocopherol recovery and fraction distribution. Molecular distillation has been studied both experimentally and through process simulation for concentrating vitamin E while limiting thermal decomposition.

This illustrates an important equipment-selection point: A molecular still does not automatically produce a certain purity. The operating window must be developed for the specific feed.

2. Natural Extracts and Bioactive Fractions

Molecular distillation is also used in the refinement and enrichment of selected natural-product fractions.

Academic reviews describe applications involving plant extracts, essential oils and other thermolabile bioactive materials used in pharmaceutical, nutraceutical and related industries.

Typical objectives include:

  • removing lighter volatile fractions;
  • concentrating selected higher-value components;
  • reducing unwanted low-molecular-weight material;
  • fractionating heat-sensitive oils;
  • improving consistency before downstream formulation.

The process is more suitable for liquid or pumpable feeds than for mixtures containing large amounts of suspended solids.

3. High-Boiling Pharmaceutical Intermediates

Some pharmaceutical intermediates are difficult to concentrate or purify because prolonged exposure to heat can cause discoloration, decomposition or unwanted reactions.

For these cases, a wiped-film or molecular-distillation process can be evaluated after upstream reaction, extraction, filtration or solvent-removal stages.

However, it is important to distinguish between: solvent evaporation/concentration and true molecular distillation of high-boiling fractions.

If the main process duty is removing a large amount of ordinary solvent, a conventional evaporator or wiped-film evaporator may be more economical. Molecular distillation is normally justified when the remaining separation requires deeper vacuum and shorter thermal exposure.

How Does Pharmaceutical Molecular Distillation Work?

A typical system follows this process:

Feed Tank → Feed Pump → Wiped-Film Evaporator → Internal Condenser → Light Fraction / Heavy Fraction → Vacuum System

The feed enters the evaporator and is distributed by the rotating wiper into a thin film.

Under vacuum:

  1. More volatile components leave the film.
  2. Vapor travels a short distance toward the internal condenser.
  3. Condensed material is collected as the light fraction.
  4. Less volatile material flows downward and is collected as the heavy fraction.

The desired product may be either fraction. This depends entirely on the molecular weight, vapor pressure and process objective.

Which Process Parameters Matter Most?

For pharmaceutical molecular distillation, the most important operating variables should be evaluated together rather than independently.

1. Vacuum Under Feed

Vacuum directly influences evaporation behavior and required temperature.

But buyers should distinguish between:

no-load vacuum — pressure reached with an empty system;

and

operating vacuum — actual pressure while material is evaporating.

Operating pressure is affected by feed rate, volatile content, temperature, vapor load, condenser performance and system leakage.

Therefore, the lowest vacuum number on a specification sheet cannot alone predict process performance.

2. Evaporator Temperature

Higher temperature can increase evaporation, but pharmaceutical and natural-product feeds will degrade if thermal exposure becomes excessive.

Vitamin E studies demonstrate that changing evaporator temperature can substantially alter which fraction contains the target compound.

3. Feed Rate

Increasing feed rate increases throughput only up to the point where film formation, heat transfer or vacuum stability becomes limiting.

Feed rate affects:

  • film thickness;
  • residence time;
  • vapor load;
  • separation ratio;
  • product purity.

For this reason, nameplate throughput should never be treated as guaranteed pharmaceutical process capacity.

4. Feed Viscosity

Highly viscous materials will require:

  • feed preheating;
  • larger feed lines;
  • suitable gear pumps;
  • temperature-controlled discharge;
  • reduced feed rate.

Viscosity also affects the ability of the wiper to produce a stable film.

5. Wiper Speed

Wiper speed affects film renewal and liquid distribution across the evaporation surface.

The optimum value depends on viscosity, feed rate, evaporator diameter and required residence behavior.

How Is Molecular Distillation Different From Other Pharmaceutical Distillation?

ProcessTypical DutyMost Suitable For
Conventional distillationBasic solvent separationVolatile, thermally stable mixtures
Fractional distillationClose-boiling volatile componentsSolvents and lighter chemical mixtures
Vacuum distillationLower-temperature distillationHigher-boiling compounds
Wiped-film evaporationSolvent removal and concentrationViscous or heat-sensitive feeds
Molecular distillationDeep-vacuum fractionationHigh-boiling, heat-sensitive, high-value materials

What Should Be Tested Before Selecting Pharmaceutical Molecular Distillation Equipment?

For a new pharmaceutical or fine-chemical feed, laboratory testing is usually more useful than selecting equipment directly from a catalog.

Important test results include:

  • feed composition;
  • viscosity and density;
  • initial and target concentration;
  • distillate/residue ratio;
  • required product recovery;
  • thermal stability;
  • achievable operating pressure;
  • evaporator temperature;
  • condenser temperature;
  • feed rate;
  • product color or degradation;
  • analytical purity before and after processing.

The results can then be used to determine whether the project requires one stage or multiple stages.

How Do You Scale Pharmaceutical Molecular Distillation From Lab to Production?

HJCHEM uses three equipment levels for process development.

1. Laboratory Development

Laboratory systems are intended for feasibility testing, parameter screening and observing film formation directly through borosilicate glass.

Typical objectives are to determine:

  • whether the separation is feasible;
  • approximate operating temperature;
  • initial vacuum requirement;
  • fraction distribution;
  • whether one or multiple stages may be needed.

2. Pilot Validation

Pilot systems use SS316L wetted parts and continuous feeding/discharge, providing a configuration closer to industrial operation.

HJCHEM pilot evaporation areas range from 0.06 to 0.50 m², with feed rates up to 50 L/h depending on model and process.

This stage is used to validate vacuum stability, pumping, film formation and longer continuous runs.

3. Industrial Production

For larger production requirements, industrial systems use SS316L wiped-film short-path evaporators with evaporation areas from 1 to 10 m² and continuous operation.

HJCHEM industrial equipment can be configured for single-stage or multi-stage processing depending on the required separation. The published equipment range reaches up to 600 L/h, but actual throughput remains process-dependent.

A typical scale-up route is therefore:

Laboratory Glass → Pilot SS316L → Industrial SS316L

rather than selecting an industrial model directly from the required daily production.

What Information Should Buyers Provide Before Requesting a System?

For pharmaceutical molecular distillation selection, provide:

  • feed material and main composition;
  • current pretreatment process;
  • feed rate or daily production;
  • viscosity and density;
  • initial and target concentration;
  • required purity;
  • expected light and heavy fractions;
  • maximum acceptable product temperature;
  • current laboratory or pilot data;
  • required operating hours;
  • solvent or volatile content;
  • material compatibility requirements;
  • cleaning requirements;
  • hazardous-area or explosion-proof requirements;
  • required documentation and certification.

If the process has not yet been validated, laboratory testing should normally come before final industrial sizing.

Conclusion

Molecular distillation has a useful but specific role in pharmaceutical processing.

It is best suited to high-boiling, heat-sensitive and high-value liquid mixtures where conventional distillation or evaporation would require excessive temperature or residence time.

The correct equipment cannot be selected from vacuum, evaporation area or nominal throughput alone. Feed composition, viscosity, thermal stability, separation target and operating pressure under load all need to be evaluated together.

For new pharmaceutical applications, the safer scale-up route is:

Confirm Feasibility → Develop Parameters → Pilot Continuous Operation → Size Industrial Equipment

Planning a pharmaceutical molecular distillation project?
Send us your feed composition, target purity, processing capacity, and any available lab data. HJCHEM can recommend a suitable lab, pilot, or industrial configuration.

Contact Us